Turkey National Mesothelioma Surveillance and Environmental Asbestos Exposure Control Program
Abstract
:1. Introduction
2. Methods
2.1. Organization
2.2. Detection of Mesothelioma Cases
2.3. Determination of the Villages with Asbestos Exposure
- (1)
- In the EAECP studies, a “from case to the field method” was used to determine the villages where there had been asbestos exposure. After obtaining the final records of the cases with MM, the cases of the people born in villages/rural areas, or the places where they used to live were determined, and the villages where people in these cases were born were included to the list of villages from which soil samples needed to be taken.
- (2)
- Health administrators performed a face-to-face survey with the governors of villages where cases were identified using a questionnaire investigating any prior or current exposure of asbestos in that particular village. If any asbestos exposure was reported, that village was also included in the above-mentioned list. Consequently, this list was submitted to both investigators and provincial health administrators of those villages.
2.4. Collection of Soil Samples from the Villages
2.5. Mineral Analysis of the Soil Samples
2.6. Calculation of Incidence Rate of Malignant Mesothelioma
2.7. Risk Map of Turkey for Environmental Asbestos Exposure
2.8. Estimates of the Population Exposed to Asbestos in Rural Turkey and the Number of Mesothelioma Cases between 2013 and 2033
2.9. Statistical Analysis
3. Results
3.1. Results of Turkey’s National Mesothelioma Surveillance
3.2. Results of Environmental Asbestos Exposure Control Program
3.3. The Incidence Rate of Malignant Mesothelioma
3.4. Estimates of the Population Exposed to Asbestos in Rural Areas of Turkey, and the Number of Mesothelioma Cases between 2013 and 2033
4. Discussion
5. Conclusions
Acknowledgments
Author Contributions
Conflicts of Interest
References
- Harber, P.; Gee, J.B.L. Clinicians’ approach to mesothelioma. In Malignant Mesothelioma; Springer: New York, NY, USA, 2015; pp. 369–379. [Google Scholar]
- Schuhmann, M.; Brims, F.J.H.; O’Reilly, K.M.A. Asbestos-Related Lung Disease: An Update. Clin. Pulm. Med. 2011, 18, 265–273. [Google Scholar] [CrossRef]
- Metintas, S.; Metintas, M.; Ucgun, I.; Onder, U. Malignant mesothelioma due to environmental exposure to asbestos. Chest 2002, 122, 2224–2229. [Google Scholar] [CrossRef] [PubMed]
- Selçuk, Z.T.; Cöplü, L.; Emri, S.; Kalyoncu, A.F.; Sahin, A.A.; Bariş, Y.I. Malignant pleural mesothelioma due to environmental mineral fiber exposure in Turkey. Analysis of 135 cases. Chest 1992, 102, 790–796. [Google Scholar]
- Metintaş, M.; Hillerdal, G.; Metintaş, S. Malignant mesothelioma due to environmental exposure to erionite: Follow-up of a Turkish emigrant cohort. Eur. Respir. J. 1999, 13, 523–526. [Google Scholar] [CrossRef] [PubMed]
- Mazurek, J.M.; Syamlal, G.; Wood, J.M.; Hendricks, S.A.; Weston, A. Malignant mesothelioma mortality—United States, 1999–2015. MMWR Morb. Mortal. Wkly. Rep. 2017, 66, 214–218. [Google Scholar] [CrossRef] [PubMed]
- Carbone, M.; Ly, B.H.; Dodson, R.F.; Pagano, I.; Morris, P.T.; Doğan, U.A.; Gazdar, A.F.; Pass, H.I.; Yang, H. Malignant mesothelioma: Facts, myths and hypotheses. J. Cell Physiol. 2012, 227, 44–58. [Google Scholar] [PubMed]
- Metintas, M. Turkey asbestos control strategic plan final report. Turkish Thorac. J. 2015, 16 (Suppl. 2), S1–S26. [Google Scholar]
- Şenyiğit, A.; Babayiğit, C.; Gökırmak, M.; Topcu, F.; Asan, E.; Coskunsel, M.; Işık, R.; Ertem, M. Incidence of malignant pleural mesothelioma due to environmental asbestos exposure in the southeast of Turkey. Respiration 2000, 67, 610–614. [Google Scholar] [CrossRef] [PubMed]
- Baris, Y.I.; Grandjean, P. Prospective study of mesothelioma mortality in Turkish villages with exposure to fibrous zeolite. J. Natl. Cancer Inst. 2006, 15, 414–417. [Google Scholar] [CrossRef] [PubMed]
- Metintas, M.; Hillerdal, G.; Metintas, S.; Dumortier, P. Endemic malignant mesothelioma: Exposure to erionite is more important than genetic factors. Arch. Environ. Occup. Health 2010, 65, 86–93. [Google Scholar] [CrossRef] [PubMed]
- Institute for Health Metrics and Evaluation. The Global Burden of Disease: Generating Evidence, Guiding Policy; Institute for Health Metrics and Evaluation: Seattle, WA, USA, 2015. [Google Scholar]
- Ahmad, O.B.; Boschi-Pinto, C.; Lopez, A.D.; Murray, J.L.C.; Lozano, R.; Inoue, M. GPE Age Standardization of Rates: A New Who Standard; GPE Discussion Paper Series: No. 31. EIP/GPE/EBD; World Health Organization, 2001. Available online: https://seer.cancer.gov/stdpopulations/world.who.html (accessed on 20 January 2017).
- Corfiati, M.; Scarselli, A.; Binazzi, A.; Di Marzio, D.; Verardo, M.; Mirabelli, D.; Gennaro, V.; Mensi, C.; Schallemberg, G.; Merler, E.; et al. Epidemiological patterns of asbestos exposure and spatial clusters of incident cases of malignant mesothelioma from the Italian national registry. BMC Cancer 2015, 15, 286. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Bayram, M.; Dongel, I.; Bakan, N.D.; Yalcin, H.; Cevit, R.; Dumortier, P.; Nemery, B. High risk of malignant mesothelioma and pleural plaque in subjects born close to ophiolites. Chest 2013, 143, 164–171. [Google Scholar] [CrossRef] [PubMed]
- Metintas, M.; Metintas, S.; Ak, G.; Erginel, S.; Alatas, F.; Kurt, E.; Ucgun, I.; Yildirim, H. Epidemiology of pleural mesothelioma in a population with non-occupational asbestos exposure. Respirology 2008, 13, 117–121. [Google Scholar] [CrossRef] [PubMed]
- Şahin, U.; Özturk, O.; Songür, N.; Bircan, A.; Akkaya, A. Observations environmental asbestos exposure in a high-risk area. Respirology 2009, 14, 579–582. [Google Scholar] [CrossRef] [PubMed]
- Metintaş, M.; Özdemir, N.; Hillerdal, G.; Uçgun, I.; Metintas, S.; Baykul, C.; Elbek, O.; Mutlu, S.; Kolsuz, M. Environmental asbestos exposure and malignant pleural mesothelioma. Respir. Med. 1999, 93, 349–355. [Google Scholar] [CrossRef]
- Baumann, F.; Carbone, M. Environmental risk of mesothelioma in the United States: An emerging concern-epidemiological issues. J. Toxicol. Environ. Health B 2016, 19, 231–249. [Google Scholar] [CrossRef] [PubMed]
- Lanphear, B.P.; Buncher, C.R. Latent period for malignant mesothelioma of occupational origin. J. Occup. Med. 1992, 34, 718–721. [Google Scholar] [PubMed]
- Bang, K.M.; Mazurek, J.M.; Storey, E.; Attfield, M.D.; Schleiff, P.L.; Wood, J.M.; Wassell, J.T. Malignant mesothelioma mortality—United States, 1999–2005. MMWR. Morb. Mortal. Wkly. Rep. 2009, 58, 393–396. [Google Scholar]
- Metintas, M.; Metintas, S.; Hillerdal, G.; Ucgun, İ.; Erginel, S.; Alataş, F.; Yıldırım, H. Non-malignant pleural lesions due to environmental exposure to asbestos. Eur. Respir. J. 2005, 26, 875–880. [Google Scholar] [CrossRef] [PubMed]
- Hillerdal, G. Mesothelioma: Cases associated with non-occupational and low dose exposures. Occup. Environ. Med. 1999, 56, 505–513. [Google Scholar] [CrossRef] [PubMed]
- Barış, Y.İ.; Akay, H.; Emri, S. Türkiye’de Asbest ve Erionite ile İlgili Hastalıklar. Toraks. Dergisi. 2007, 8 (Suppl. 1), 1–24. [Google Scholar]
- Sterman, D.H.; Albelda, S.M. Advances in the diagnosis, evaluation and management of malignant pleural mesothelioma. Respirology 2005, 10, 266–283. [Google Scholar] [CrossRef] [PubMed]
- Batirel, H.F.; Metintas, M.; Caglar, H.B.; Ak, G.; Yumuk, P.F.; Yildizeli, B.; Yuksel, M. Adoption of pleurectomy and decortication for malignant mesothelioma leads to similar survival as extrapleural pneumonectomy. J. Thorac. Cardiovasc. Surg. 2016, 151, 478–484. [Google Scholar] [CrossRef] [PubMed]
- Ak, G.; Metintas, S.; Metintas, M.; Yildirim, H.; Erginel, S.; Kurt, E.; Alatas, F.; Cadirci, O. Prognostic factors according to the treatment schedule in malignant pleural mesothelioma. J. Thorac. Oncol. 2009, 4, 1425–1430. [Google Scholar] [CrossRef] [PubMed]
- Tossavainen, A. Global use of asbestos and the incidence of mesothelioma. Int. J. Occup. Environ. Health 2004, 10, 22–25. [Google Scholar] [CrossRef]
- Hodgson, J.T.; McElvenny, D.M.; Darnton, A.J.; Price, M.J.; Peto, J. The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050. Br. J. Cancer 2005, 92, 587–593. [Google Scholar] [CrossRef]
- Health and Safety Executive. Mesothelioma Mortality in Great Britain. The Revised Risk and Two-Stage Clonal Expansion Models; Research Report 876; HSE Books: London, UK, 2011.
- Australian Mesothelioma Registry. 1st Annual Report Mesothelioma in Australia 2011, Safe Work Australia. 2011. Available online: http://www.mesothelioma-australia.com (accessed on 20 October 2016).
- Marsili, D.; Terracini, B.; Santana, V.S.; Ramos-Bonilla, J.P.; Pasetto, R.; Mazzeo, A.; Loomis, D.; Comba, P.; Algranti, E. Prevention of Asbestos-Related Disease in Countries Currently Using Asbestos. Int. J. Environ. Res. Public Health 2016, 13, 494. [Google Scholar] [CrossRef]
Variables | Male (n = 3241) n (%) | Female (n = 2376) n (%) | Total (n = 5617) n (%) | p |
---|---|---|---|---|
Years | 0.246 | |||
2008 | 570 (17.6) | 422 (17.8) | 992 (17.7) | |
2009 | 658 (20.3) | 455 (19.1) | 1113 (19.8) | |
2010 | 606 (18.7) | 498 (21.0) | 1104 (19.7) | |
2011 | 686 (21.2) | 501 (21.1) | 1187 (21.1) | |
2012 | 721 (22.2) | 500 (21.0) | 1221 (21.7) | |
Age (years) | 0.071 | |||
<40 | 169 (5.3) | 154 (6.5) | 323 (5.8) | |
40–49 | 385 (11.9) | 309 (13.0) | 694 (12.4) | |
50–59 | 789 (24.3) | 573 (24.1) | 1362 (24.2) | |
60–69 | 905 (27.9) | 603 (25.4) | 1508 (26.8) | |
70+ | 993 (30.6) | 737 (31.0) | 1730 (30.8) | |
Born or living in the rural area | 0.04 | |||
Yes | 2122 (65.5) | 1616 (68.0) | 3738 (66.5) | |
No | 1119 (34.5) | 760 (31.0) | 1879 (33.5) | |
Vital status | <0.001 | |||
Dead | 2097 (64.7) | 1398 (58.8) | 3495 (62.2) | |
Alive | 1144 (35.3) | 978 (41.2) | 2122 (37.8) | |
Site of lesion | <0.001 | |||
Pleura | 3117 (96.2) | 2225 (93.6) | 5342 (95.1) | |
Peritoneum | 110 (3.4) | 136 (5.7) | 246 (4.4) | |
Pericardium | 14 (0.4) | 15 (0.7) | 29 (0.5) |
Crude Incidence Rate Annual per 100,000 (95% CI) | Standardized Incidence Rate * Annual per 100,000 (95% CI) | |
---|---|---|
Turkey | ||
Male | 1.86 (1.79–1.89) | 2.88 (2.86–2.89) |
Female | 1.49 (1.43–1.56) | 1.86 (1.85–1.87) |
Total | 1.84 (1.79–1.92) | 2.33 (2.32–2.34) |
Villages with continuing asbestos exposure ** | ||
Male | 79.94 (67.64–92.17) | 87.27 (87.21–87.33) |
Female | 66.92 (55.84–78.00) | 68.44 (68.39–68.49) |
Total | 73.42 (65.30–81.67) | 79.00 (78.94–79.06) |
Variables | Rate Annual per 100,000 | Risk Ratio | 95% CI |
---|---|---|---|
Gender | |||
Male | 1.86 | 1 | |
Female | 1.49 | 0.80 | 0.76–0.84 |
Male | |||
<40 | 0.27 | 1 | |
40–49 | 1.23 | 4.56 | 3.76–5.53 |
50–59 | 2.83 | 10.48 | 8.77–12.52 |
60–69 | 4.55 | 16.85 | 14.12–20.11 |
≥70 | 6.39 | 23.67 | 19.90–28.16 |
Female | |||
<40 | 0.26 | 1 | |
40–49 | 1.36 | 5.23 | 4.58–5.97 |
50–59 | 3.37 | 12.96 | 11.48–14.63 |
60–69 | 5.93 | 22.81 | 20.23–25.72 |
≥70 | 8.70 | 33.46 | 29.71–37.68 |
Asbestos in the village | |||
No | 0.75 | 1 | |
Yes | 8.08 | 10.77 | 9.14–12.69 |
TUNMES Organization | |||
No | 0.37 | 1 | |
Yes | 1.40 | 3.78 | 3.34–4.28 |
© 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Metintaş, S.; Batırel, H.F.; Bayram, H.; Yılmaz, Ü.; Karadağ, M.; Ak, G.; Metintaş, M. Turkey National Mesothelioma Surveillance and Environmental Asbestos Exposure Control Program. Int. J. Environ. Res. Public Health 2017, 14, 1293. https://doi.org/10.3390/ijerph14111293
Metintaş S, Batırel HF, Bayram H, Yılmaz Ü, Karadağ M, Ak G, Metintaş M. Turkey National Mesothelioma Surveillance and Environmental Asbestos Exposure Control Program. International Journal of Environmental Research and Public Health. 2017; 14(11):1293. https://doi.org/10.3390/ijerph14111293
Chicago/Turabian StyleMetintaş, Selma, Hasan Fevzi Batırel, Hasan Bayram, Ülkü Yılmaz, Mehmet Karadağ, Güntülü Ak, and Muzaffer Metintaş. 2017. "Turkey National Mesothelioma Surveillance and Environmental Asbestos Exposure Control Program" International Journal of Environmental Research and Public Health 14, no. 11: 1293. https://doi.org/10.3390/ijerph14111293
APA StyleMetintaş, S., Batırel, H. F., Bayram, H., Yılmaz, Ü., Karadağ, M., Ak, G., & Metintaş, M. (2017). Turkey National Mesothelioma Surveillance and Environmental Asbestos Exposure Control Program. International Journal of Environmental Research and Public Health, 14(11), 1293. https://doi.org/10.3390/ijerph14111293